However, it is also possible that TGFB has both pro-tumor and antitumor activities in GBM as in other non-CNS cancers.13,14 Therefore, it is critical to develop a comprehensive understanding of the TGFB/GAM axis in glioma to develop refined, specific targets. This evidence concerns the gene TGFB1 and central nervous system cancer.